Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.57%14.35B | 1.21%13.22B | 3.87%3.32B | -8.96%3.43B | 10.88%3.34B | 1.40%3.12B | 17.18%13.06B | 4.31%3.2B | 28.71%3.76B | 18.78%3.02B |
| Cost of revenue | 5.60%12.22B | 0.50%11.57B | 0.17%2.83B | -6.39%2.98B | 7.93%2.9B | 1.50%2.86B | 19.41%11.51B | 4.14%2.83B | 30.13%3.18B | 21.35%2.69B |
| Gross profit | 29.44%2.13B | 6.52%1.65B | 31.70%493.66M | -23.07%446.35M | 35.17%441.62M | 0.32%263.53M | 2.87%1.54B | 5.60%374.82M | 21.47%580.21M | 1.14%326.72M |
| Operating expense | 6.71%1.71B | 7.34%1.6B | 16.83%416.37M | 0.99%364.1M | -1.94%415.65M | 15.43%406.08M | 4.52%1.49B | -3.03%356.4M | 6.71%360.52M | 22.54%423.88M |
| Operating profit | 877.01%419.71M | -17.17%42.96M | 319.51%77.29M | -62.56%82.25M | 126.73%25.97M | -59.99%-142.55M | -29.31%51.86M | 246.40%18.42M | 57.14%219.7M | -324.92%-97.16M |
| Net non-operating interest income (expenses) | 1,019.51%12.91M | 110.18%1.15M | 151.80%1.07M | 132.66%1.04M | 127.96%795K | 46.04%-1.75M | 8.00%-11.33M | 32.35%-2.06M | 3.83%-3.19M | 0.49%-2.84M |
| Non-operating interest income | 81.21%27.37M | 609.87%15.11M | 322.34%4.97M | 542.56%4.36M | 2,135.67%3.51M | 1,866.96%2.26M | 106.20%2.13M | 576.44%1.18M | 528.70%679K | -47.67%157K |
| Non-operating interest expense | 3.67%14.47M | 3.69%13.95M | 20.71%3.91M | -14.07%3.32M | -9.50%2.72M | 19.52%4.01M | 0.83%13.46M | 0.59%3.24M | 12.97%3.87M | -4.97%3M |
| Net investment income | 70.48%147.72M | -32.70%86.65M | -55.02%7.54M | 42.37%62.6M | -45.20%20.69M | -113.77%-4.17M | 120.82%128.76M | 198.41%16.75M | 277.76%43.97M | 392.16%37.75M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -65.34%85.65M | 1,538.41%247.1M | 1,396.20%222.68M | 0 | 0 | 24.43M | -115.58%-17.18M | -17.18M | 0 | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 197.13%51.57M | -311.30%-53.1M | -100.70%-25.91M | -27.19M | 0 | 0 | 73.67%-12.91M | -189.37%-12.91M | 0 | 0 |
| Less:Other special charges | -252.52%-56.68M | 2,961.12%37.16M | --9.98M | ---- | ---- | ---- | -97.52%1.21M | ---- | ---- | ---- |
| Less:Write off | -67.92%5.11M | 36.24%15.93M | ---- | ---- | ---- | ---- | --11.7M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -75.15%2.75M | -48.81%11.07M | -3.26%7.27M | 359.33%11.86M | -176.79%-7.16M | -140.33%-891K | 610.29%21.63M | 302.36%7.51M | 348.03%2.58M | 253.78%9.33M |
| Income before tax | 114.48%720.32M | 108.81%335.84M | 2,650.71%289.93M | -50.37%130.56M | 176.11%40.28M | -108.77%-124.93M | -8.80%160.83M | 183.60%10.54M | 136.17%263.06M | -244.62%-52.92M |
| Income tax | 36.48%211.97M | 3.57%155.31M | 135.70%93.72M | -41.42%38.3M | -102.16%-268K | -27.28%23.55M | 127.19%149.96M | 1,473.07%39.76M | 80.93%65.38M | 328.43%12.43M |
| Net income | 181.58%508.35M | 1,560.25%180.54M | 771.37%196.2M | -53.33%92.26M | 162.05%40.55M | -60.99%-148.48M | -90.15%10.87M | -200.91%-29.22M | 162.70%197.68M | -255.47%-65.36M |
| Net income continuous operations | 181.58%508.35M | 1,560.10%180.54M | 771.37%196.2M | -53.33%92.26M | 162.05%40.55M | -60.99%-148.48M | -90.14%10.88M | -200.91%-29.22M | 162.69%197.68M | -255.47%-65.36M |
| Noncontrolling interests | 287.61%196.64M | -54.62%50.73M | 38.22%36.39M | -41.12%32.94M | -84.77%2.78M | -289.47%-21.37M | 80.73%111.79M | 155.34%26.33M | 306.58%55.94M | 175.75%18.24M |
| Net income attributable to the company | 140.14%311.71M | 228.63%129.81M | 387.69%159.81M | -58.14%59.33M | 145.19%37.77M | -22.80%-127.11M | -308.10%-100.91M | -177.44%-55.55M | 130.50%141.74M | -336.01%-83.6M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 140.14%311.71M | 228.63%129.81M | 387.69%159.81M | -58.14%59.33M | 145.19%37.77M | -22.80%-127.11M | -308.10%-100.91M | -177.44%-55.55M | 130.50%141.74M | -336.01%-83.6M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 140.21%98.75 | 229.40%41.11 | 388.87%50.61 | -57.64%18.79 | 145.50%11.97 | -24.64%-40.26 | -312.37%-31.77 | -185.34%-17.52 | 134.21%44.36 | -341.38%-26.31 |
| Diluted earnings per share | 140.21%98.75 | 229.40%41.11 | 387.65%50.61 | -57.64%18.79 | 145.28%11.9639 | -24.64%-40.26 | -312.37%-31.77 | -182.54%-17.5944 | 134.21%44.36 | -342.41%-26.4226 |
| Dividend per share | 25.00%25 | 0.00%20 | 0.00%20 | 0 | 0 | 0 | 0.00%20 | 0.00%20 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |